1
TITLE: Chromenone Derivatives as CRM1 Inhibitors for Targeting Glioblastoma  Full Text
AUTHORS: Princiotto, Salvatore; Jimenez, Lucia; Dominguez, Lucia; Sequeira, Joao G. N.; Mourato, Cristiana; Orea Soufi, Alba; Santos, Bruno; Dallavalle, Sabrina; Machuqueiro, Miguel; Ferreira, Bibiana I.; Link, Wolfgang;
PUBLISHED: 2025, SOURCE: CHEMBIOCHEM
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
2
TITLE: 2024 Annual Meeting of the International Network on Ectopic Calcification (INTEC)—Abstract Proceedings
AUTHORS: Leonor L Cancela; Ahmed Alouane; Pietro M Bertelli; Antonio Camacho; Robbe Derudder; Antonella Forlino; Matthew P Harris; Marta Jacinto; Imre Lengyel; Wolfgang Link; Monzur Murshed; Andreas Pasch; Arun-Kumar Kaliya-Perumal; Daniela Quaglino; Zihan Qin; Yves Sabbagh; Elena Seminari; Marcos M Villar; Christoph Winkler; Olivier M Vanakker;
PUBLISHED: 2025, SOURCE: Gout, Urate, and Crystal Deposition Disease, VOLUME: 3, ISSUE: 3
INDEXED IN: CrossRef
IN MY: ORCID
3
TITLE: TRIB2 supports a high glycolytic phenotype in melanoma cells
AUTHORS: Victor Mayoral-Varo; Ana Luísa De Sousa-Coelho; Carla Lopes; Óscar H Martínez-Costa; Paulo J Oliveira; Juan J Aragón; Bibiana I Ferreira; Wolfgang Link;
PUBLISHED: 2025
INDEXED IN: CrossRef
IN MY: ORCID
4
TITLE: Resistance to Carcinogenesis in the African Spiny Mouse (Acomys) correlates with upregulation of tumor suppressor genes
AUTHORS: Marta Vitorino; Gonçalo G Pinheiro; Ines M Araujo; Bibiana I Ferreira; Wolfgang Link; Gustavo Tiscornia;
PUBLISHED: 2024
INDEXED IN: CrossRef
IN MY: ORCID
5
TITLE: Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT (Nature Communications, (2017), 8, 1, (14687), 10.1038/ncomms14687)
AUTHORS: Richard Hill; Patricia Madureira; Bibiana Ferreira; Inês Baptista; Susana Machado; Laura Colaҫo; Marta dos Santos; Ningshu Liu; Ana Dopazo; Selma Ugurel; Angyal Adrienn; Endre Kiss Toth; Murat Isbilen; Ali Gure; Wolfgang Link;
PUBLISHED: 2023, SOURCE: Nature Communications, VOLUME: 14, ISSUE: 1
INDEXED IN: Scopus CrossRef
IN MY: ORCID
6
TITLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT (Retraction of Vol 8, art no 14687, 2017)
AUTHORS: Hill, Richard; Madureira, Patricia A. A.; Ferreira, Bibiana; Baptista, Ines; Machado, Susana; Colaco, Laura; dos Santos, Marta; Liu, Ningshu; Dopazo, Ana; Ugurel, Selma; Adrienn, Angyal; Kiss Toth, Endre; Isbilen, Murat; Gure, Ali O. O.; Link, Wolfgang;
PUBLISHED: 2023, SOURCE: NATURE COMMUNICATIONS, VOLUME: 14, ISSUE: 1
INDEXED IN: WOS
7
TITLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
AUTHORS: Hill, R; Madureira, PA; Ferreira, B; Baptista, I; Machado, S; Colaco, L; dos Santos, M; Liu, NS; Dopazo, A; Ugurel, S; Adrienn, A; Kiss Toth, E; Isbilen, M; Gure, AO; Link, W;
PUBLISHED: 2017, SOURCE: NATURE COMMUNICATIONS, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 65
IN MY: ORCID
8
TITLE: Special Review Caught in the Crosshairs: Targeted Drugs and Personalized Medicine
AUTHORS: Bibiana I Ferreira; Richard Hill; Wolfgang Link;
PUBLISHED: 2015, SOURCE: CANCER JOURNAL, VOLUME: 21, ISSUE: 6
INDEXED IN: WOS
9
TITLE: Discovery of novel inhibitor of FOXO nuclear-cytoplasmic shuttling from natural products of marine origin  Full Text
AUTHORS: Castillo Correa, FJC; De Pedro, N; Rodriguez Quesada, LR; Oves Costales, DO; Tormo, JR; Martin, J; Reyes, F; Genilloud, O; Vicente, F; Link, W; Cautain, B;
PUBLISHED: 2014, SOURCE: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in EUROPEAN JOURNAL OF CANCER, VOLUME: 50
INDEXED IN: WOS
10
TITLE: Image-based high-throughput screening for inhibitors of angiogenesis
AUTHORS: Evensen, L; Link, W; Lorens, JB;
PUBLISHED: 2012, SOURCE: Methods in Molecular Biology, VOLUME: 931
INDEXED IN: Scopus
Page 1 of 2. Total results: 15.